As of 2025-07-11, the Intrinsic Value of Immunic Inc (IMUX) is -5.03 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.81 USD, the upside of Immunic Inc is -724.23%.
Based on its market price of 0.81 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 724.23%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.03 - -5.03 | -5.03 | -724.23% |
| P/E | (22.29) - (12.72) | (16.85) | -2191.2% |
| DDM - Stable | (6.15) - (25.20) | (15.68) | -2045.8% |
| DDM - Multi | (2.01) - (6.87) | (3.16) | -492.6% |
| Market Cap (mil) | 77.21 |
| Beta | 1.05 |
| Outstanding shares (mil) | 95.82 |
| Enterprise Value (mil) | 62.91 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.52% |
| Cost of Debt | 5.00% |
| WACC | 7.59% |